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Melation (M) is a pineal hormone attracting attention with its en-
docrine and antineoplastic effects. It penetrates all biomembranes, 
easily reaches cell nucleus and may influence directly on mitotic ac-
tivity. 
Recently it is proven that inhibition of M synthesis depresses 
megakaryocytopoiesis. Having in mind all this we formulated our aim 
to study M effects on thrombocytopoiesis and plasma thrombocyto-
poietin activity (TPA) in rats. 
The trial covered 60 white male Wistar rats and 30 male mice of 
Swiss breed. Rats were divided into 2 main groups. Effects of M on 
some basic parameters of thrombocytopoiesis - thrombocyte count, 
percentage of ^Selenomethionine ( Se-M) incorporation in newly-
formed platelets and bone marrow megakaryocytes (MKC) was in-
vestigated in the first main group, divided into two subgroups. 
Melatonin (Merck, Germany) was applied in a dose 2 mg/k£ b.m. 
twice daily, s .c. for 3 consecutive days at 12 h dark/light exposure. 
TPA of the 2 main group of rats was determined after Penington's 
method - our modifica-
, 0 ' / L tion. TPA level was es-
timated according to 
the shifts of platelet 
count and percentage 
of isotope incorpora-
tion in recipient mice. 
Data were processed 
by the methods of vari-
at ion a n a l y s i s . I n -
f luence of M on 
thrombocytopoiesis is 
shown on fig.1-ab. It is 
obv ious that M i n -
c reases significantly 
not only thrombocyte 
count ( f ig . 1 - a ) - by 
80,23% (p< 0.001) but 
a l s o p e r c e n t a g e of 
9 ^ 0 , 1 & 





rig. 1-а: Changes in thrombocyte count; 
Fig. 1-b: Percentage of1*Se-M incorpora­
tion in newly-formed thrombocytes 
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7 5 S e - M incorporation in newly-formed platelets (fig. 1-b) - by 80,07% 
(p< 0,001). 
Bone marrow MKC show significant increase not only of their 
total count by 83,73% 
(p<0,001) but also of ,0*/L 
all cell stages: I - by 
61,66% (p<0,001); II -
by 74,35% (p< 0,001); 
I I I - by 1 1 8 , 1 8 % 
( p < 0 , 0 0 1 ) and IV 
stage - by 1 5 0 , 0 0 % 
(p< 0 , 0 0 1 ) . T P A ob­
tained from M treated 
donors is illustrated on 
fig.2-ab. It is evident 
that both thrombocyte 
count (fig.2-a) and per­
centage of Se-M in­
corporation (fig.2-b) 
are i n c r e a s e d by 
1 2 0 , 7 5 % ( p < 0 , 0 0 1 ) 
and 7 0 , 1 2 % ( p < 
0 ,001) , respectively. 
Data analysis shows 
that M elevates signifi­
cant ly al l examined 
parameters of thrombocytopoiesis - thrombocyte count, percentage 
of Se-M incorporation (fig.1-ab) and bone marrow MKC and this is 
a valid criterion of its stimulation. 
Having in mind that the total count of MKC and stages I and II 
characterise the level of proliferation and stages III and IV - diferen-
tiation of these cells, it is obvious that M activates these processes. 
The increase of platelet count and Se-M incorporation in recipient 
mice (fig.2-ab) by plasma from M treated donors shows higher TPA 
level. 
For this reason it could be assumed that most probably M stimu­
lated thrombocytopoiesis is predominantly a result of a significantly 
enhanced biosynthesis of the specific humoral regulator of this pro­
cess - thrombocytopoietin. 
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Fig. 2-a: Changes in thrombocyte count; 
Fig. 2-b: Percentage of Se-M incorpor­
ation in newly-formed thrombocytes in 
recipient-mice. Plasma M- plasma of M 
treated donors; Plasma С - controls 
